Cartesian Therapeutics, Inc. number of employees

Cartesian Therapeutics, Inc. reported 75 employees at December 31, 2025 in its latest annual report. Revenue per employee was $37,293.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	75	—	$37,293	10-K, filed March 9, 2026

What the annual reports say

As of December 31, 2025, we had 75 full-time employees, 62 of whom are primarily engaged in research and development activities and 13 of whom are primarily engaged in corporate functions. 60% of our employees have at least one of a Masters, PhD, or MD degree. 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ABSI vs RNAC OVID vs RNAC DARE vs RNAC LGVN vs RNAC

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cartesian Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cartesian Therapeutics, Inc.